PortfoliosLab logoPortfoliosLab logo

The Best Health & Biotech Equities ETFs

The table below compares the performance and other essential indicators like dividend yield and expense ratio of Health & Biotech Equities ETFs.

Health & Biotech Equities ETFs are exchange-traded funds that invest in a diversified portfolio of companies that operate in the healthcare and biotechnology sectors. These sectors include companies involved in the research, development, and production of medical products, drugs, and therapies. They can also include companies that provide healthcare services, such as hospitals, insurance companies, and medical device manufacturers.

Health & biotech ETFs can provide investors with exposure to the growth potential of these sectors, which are driven by factors such as demographic changes, technological advancements, and growing demand for healthcare services. However, it's important to note that these ETFs can be more volatile and risky than the overall market, as the success of many companies in this sector is heavily dependent on clinical trial results and regulatory approvals.

Number of ETFs
65
Avg. Expense Ratio
0.59%
Avg. Dividend Yield
3.21%
Avg. 1 Year Return
25.11%
Median Risk/Return Score
37 / 100
The Best Health & Biotech Equities ETFs

4 results

SymbolFull NameCategoryInceptionExpense RatioYTD Return10Y Return (Annualized)Dividend Yield

Risk / Return Rank

Max. DrawdownSharpe RatioSortino RatioOmega RatioMartin RatioCalmar RatioUlcer Index
iShares US Medical Devices UCITS ETFHealth & Biotech EquitiesAug 3, 20200.25%
-21.33%
0.00%
1
iShares MSCI World Health Care Sector Advanced UCI...Health & Biotech EquitiesNov 1, 20210.18%
-2.07%
0.00%
17
iShares MSCI World Health Care Sector UCITS ETF US...Health & Biotech EquitiesOct 17, 20191.00%
-3.10%
1.08%
20
SPDR MSCI World Health Care UCITS ETFHealth & Biotech EquitiesApr 29, 20160.30%
-1.97%
7.60%
0.00%
21

Rows per page

1–4 of 4

Best Health & Biotech Equities ETFs by Risk/Return Score

The top Health & Biotech Equities ETFs by PortfoliosLab Risk/Return Score are BBC (88) and IHE (83). The score measures risk-adjusted performance over the past year, accounting for volatility, drawdown, and return consistency.

Best-Performing Health & Biotech Equities ETFs Over 5 Years

The top Health & Biotech Equities ETFs is IHE (10.63%). Across the lineup, Health & Biotech Equities ETFs show an average 1-year return of 25.11% and an average 5-year return of 0.21%, providing a clearer view of performance across different investment horizons.

SymbolNameReturn 5YAUMInception
iShares U.S. Pharmaceuticals ETF
10.63%
912.87MMay 2006
Virtus LifeSci Biotech Products ETF
10.41%
78.56MDec 2014
VanEck Vectors Pharmaceutical ETF
10.11%
941.75MDec 2011
First Trust Nasdaq Pharmaceuticals ETF
8.37%
35.04MSep 2016
Invesco Dynamic Pharmaceuticals ETF
8.32%
341.25MJun 2005

Lowest-Cost Health & Biotech Equities ETFs

The top Health & Biotech Equities ETFs is FHLC (0.08%). With an average expense ratio of 0.59%, Health & Biotech Equities ETFs remain a low-cost option for investors seeking broad market exposure, sector allocations, and diversified portfolio building blocks.

Highest-Yield Health & Biotech Equities ETFs

The top Health & Biotech Equities ETFs is HIYY (94.23%). Across the lineup, Health & Biotech Equities ETFs show an average dividend yield of 3.21%, offering investors a steady stream of income through regular dividend payments, making them attractive for income-seeking portfolios.

Top ETFs Categories


Top ETFs Comparisons

Compare the top ETFs symbols based on PortfoliosLab usage data.

Risk vs. Return Scatterplot

The Risk vs. Return Scatterplot allows you to quickly compare funds, stocks, and ETFs in one view. It displays the yearly return of an instrument on one axis and the risk (volatility) on the other.

0%Annualized Volatility0%Annualized Return

Loading charts...